SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus

被引:70
作者
Imoto, I
Pimkhaokham, A
Fukuda, Y
Yang, ZQ
Shimada, Y
Nomura, N
Hirai, H
Imamura, M
Inazawa, J
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Div Genet,Bunkyo Ku, Tokyo 1138510, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan
[3] Kazusa DNA Res Inst, Facil RI Expt, Kisarazu, Japan
[4] Univ Tokyo, Fac Med, Dept Hematol & Oncol, Tokyo 113, Japan
关键词
amplification; 3q26; SNO; EVI1; PIK3CA; TERC; esophageal squamous cell carcinoma;
D O I
10.1006/bbrc.2001.5428
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amplification of the 3q26 region appears to occur frequently among esophageal squamous cell carcinomas (ESCs). We examined ESC cell lines for amplification and expression levels of four genes in this region: SNO and EVI1, which encode proteins antagonizing transforming growth factor-beta signaling, and two other putative target genes, TERC and PIK3CA Amplification of SNO was accompanied by significant increases in its expression level, suggesting that this gene is activated in an amplification-dependent manner. SNO was also amplified in 5 of 44 primary ESCs (11.4%). However, expression levels of EVI1, TERC, and PIK3CA did not correlate with their copy-numbers, even though EVI1 and TERC showed the same amplification pattern as SNO. Taken together, the data suggest that of the four candidates, SNO is the most probable target in the 3q26 amplicon for involvement in the progression of ESC. (C) 2001 Academic Press.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 48 条
[1]   CLONAL ORIGIN OF PHILADELPHIA-CHROMOSOME NEGATIVE CELLS WITH TRISOMY-8 APPEARING DURING THE COURSE OF ALPHA-INTERFERON THERAPY FOR PH POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA [J].
ARIYAMA, T ;
INAZAWA, J ;
UEMURA, Y ;
KAKAZU, N ;
MAEKAWA, T ;
URASE, F ;
IRIMAJIRI, K ;
HORIUCHI, A ;
NAKAMURA, Y ;
ABE, T .
CANCER GENETICS AND CYTOGENETICS, 1995, 81 (01) :20-23
[2]   Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas [J].
Bergamo, NA ;
Rogatto, SR ;
Poli-Frederico, RC ;
Reis, PP ;
Kowalski, LP ;
Zielenska, M ;
Squire, JA .
CANCER GENETICS AND CYTOGENETICS, 2000, 119 (01) :48-55
[3]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[4]  
BOYER PL, 1993, ONCOGENE, V8, P457
[5]  
Brass N, 1997, CANCER RES, V57, P2290
[6]  
Chen LC, 1998, CANCER RES, V58, P3677
[7]   MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].
Eppert, K ;
Scherer, SW ;
Ozcelik, H ;
Pirone, R ;
Hoodless, P ;
Kim, H ;
Tsui, LC ;
Bapat, B ;
Gallinger, S ;
Andrulis, IL ;
Thomsen, GH ;
Wrana, JL ;
Attisano, L .
CELL, 1996, 86 (04) :543-552
[8]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[9]   TGF-β signaling and cancer:: structural and functional consequences of mutations in Smads [J].
Hata, A ;
Shi, YG ;
Massague, J .
MOLECULAR MEDICINE TODAY, 1998, 4 (06) :257-262
[10]   Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix [J].
Heselmeyer, K ;
Schrock, E ;
duManoir, S ;
Blegen, H ;
Shah, K ;
Steinbeck, R ;
Auer, G ;
Ried, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :479-484